The Recuperation of Patients After Elective Shoulder Surgery Observational Cohort Study

NCT03335410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2018-09-06

No results posted yet for this study

Summary

Around 6400 shoulder surgeries are performed yearly in Finland. The procedure is mainly day-case surgery and the patients go home in the afternoon. Shoulder surgery is one of the most common procedures performed in private surgical practices. Because of the complex nature of the joint, the recovery may be complicated by severe opstoperative pain, which is relieved with strong opioids. Recently this has been addressed in the literature, as prescribed opioids too often lead to substance abuse. Pain in the acute phase after surgery is one of the common risk factors for persistent postoperative pain, which is a major burden for both the individual patient and the society.

In this prospective, observational cohort study we aim to describe current standards of practice in planning and taking care of anaeshtesia and prescribing opioids and adjuvants for postoperative pain relief at home.

Conditions

  • Aucte Pain After Surgery
  • Persistent Pain After Surgery
  • Opioid Use After Surgery
  • Mode of Anaesthesia

Interventions

OTHER

Non- interventional

Non- interventional

Sponsors & Collaborators

  • Turku University Hospital

    collaborator OTHER_GOV
  • Oulu University Hospital

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Hatanpää Hospital, Tampere

    collaborator UNKNOWN
  • Middle Finland Central Hospital, Jyväskylä

    collaborator UNKNOWN
  • Pihlajalinna, Tampere

    collaborator UNKNOWN
  • Terveystalo, Turku

    collaborator UNKNOWN
  • Satakunta Central Hospital, Pori

    collaborator UNKNOWN
  • Päijänne Tavastia Central Hospital

    collaborator OTHER
  • Vaasa Central Hospital, Vaasa, Finland

    collaborator OTHER
  • Tampere University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-01-15
Completion
2018-01-15

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335410 on ClinicalTrials.gov